Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Pathogenesis and Immunity

Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation

Sheila A. Stewart, Betty Poon, Joo Y. Song, Irvin S. Y. Chen
Sheila A. Stewart
Departments of Microbiology and Immunology and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betty Poon
Departments of Microbiology and Immunology and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joo Y. Song
Departments of Microbiology and Immunology and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irvin S. Y. Chen
Departments of Microbiology and Immunology and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.74.7.3105-3111.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Vpr expressed from the retroviral vector HR′Vpr is sufficient to induce apoptosis. (A) Representative diagram of Annexin V staining of mock-, HR′Thy-, and HR′Thy (Vpr+)-infected HeLa cells. Flourescence intensity of Annexin-V-FITC is represented on thex axis, and flourescence intensity of 7-AAD is represented on the y axis. The population in the lower left quadrant represents the live cells, the cells in the upper right quadrant represent the dead cell population, and the lower right quadrant represents the apototic cell population. (B) Bar graph represents five independent experiments showing the percentages of mock- (open bars), HIV-1NL4-3Thyenv(−)VprX/VSV-G- (hatched bars), and HIV-1NL4-3Thyenv(−)/VSV-G-infected cells (filled bars) staining Annexin V positive 48 h postinfection. Values obtained with HIV-1NL4-3Thyenv(−)/VSV-G were significantly different from those obtained with HIV-1NL4-3Thyenv(−)VprX/VSV-G, which in turn were higher than those obtained from media alone (P < 0.0001 by Page's test for ordered alternatives in a two-way layout) (22). (C) Bar graph represents three independent experiments showing the percentages of mock- (open bars), HR′Thy(Vpr−)- (hatched bars), and HR′Vpr-infected cells (filled bars) staining Annexin V positive 72 h postinfection. Values obtained with HR′Vpr were significantly higher than those obtained with HR′Thy(Vpr−), which in turn were higher than those obtained with media alone (P < 0.0001 by Skillings-Wolf nonparametric test for ordered alternatives in a two-way unbalanced layout) (22).

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    CrmA and p35 reduce Vpr-induced apoptosis. Transfection efficiencies were analyzed by flow cytometry at 48 h posttransfection. The data shown is representative of three independent experiments. (A) Bar graph representing Annexin V staining of cells transfected with the indicated viral anti-apoptosis gene and infected with HIV-1NL4-3Thyenv(−)/VSV-G. The percentage of Annexin V staining is represented on the y axis. The data indicated are results from 72 h posttransfection and 48 h postinfection. (B) Bar graph representing Annexin V staining of cells transfected with the indicated viral anti-apoptosis gene and infected with HIV-1NL4-3Thyenv(−)VprX/VSV-G. The percentage of Annexin V staining is represented on the y axis. The data indicated are results from 72 h posttransfection and 48 h postinfection.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Synthetic peptide inhibitor of apoptosis has no significant effect on cell cycle arrest but does reduce the amount of Vpr-induced apoptosis. HeLa cells (105) were mock infected or infected with HR′Vpr. Following infection, cells were washed and 200 μM z-VAD-fmk was added (filled bars). In addition, one set of infected cultures (open bars) received DMSO alone, which was used to dissolve the inhibitors. Fresh inhibitor was added every 24 h throughout the experiment. Infected cells were analyzed 72 h postinfection. Data shown is representative of three independent experiments.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Synthetic caspase inhibitor protects human T cells from Vpr-induced apoptosis. SupT1 cells (4 × 105) were mock infected or infected with HR′Vpr for 4 h in the presence of 10 μg of polybrene per ml. Following infection, cells were washed and DMSO or 100 μM z-VAD-fmk, dissolved in DMSO, was added. Fresh DMSO or z-VAD-fmk was added every 24 h for the duration of the experiment. The experiment was carried out in triplicate, and percentage of apoptosis is plotted against time for HR′Vpr-infected cells treated with either DMSO or z-VAD-fmk as indicated. The difference between estimated mean response at day 3 is significantly lower for z-VAD treatment than for treatment with DMSO (P < 0.005 by testing contrasts for fixed effects in a mixed linear model for repeated measurements) (30).

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Synthetic peptide inhibitor of apoptosis reduces the levels of apoptosis while increasing the amount of p24 produced during an HIV-1 infection. HeLa cells (105) were infected with HIV-1NL4-3Thyenv(−)/VSV-G for 4 h in the presence of 10 μg of polybrene per ml. Following infection, the cells were washed twice with PBS and fresh media containing DMSO or 100 μM z-VAD-fmk, dissolved in DMSO, was added. Every 12 h, fresh DMSO or z-VAD-fmk was added to the media. The data shown is representative of four independent experiments. (A) Bar graph representing the percentage of Annexin V-staining cells within the cultures infected with HIV-1NL4-3Thyenv(−)/VSV-G 72 h postinfection. Thy 1.2 analysis revealed that 47.1% of the cells were infected at 48 h postinfection. (B) Bar graph representing p24 (ng/ml) at 84 h postinfection. In each of four independent experiments, we observed a similar negative association: DMSO-treated cultures had higher levels of Annexin V-positive cells and lower levels of p24 than z-VAD-fmk-treated cultures (P = 0.06 by testing the signs of independent Spearman rank correlations for evidence of no association versus negative association) (22).

PreviousNext
Back to top
Download PDF
Citation Tools
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation
Sheila A. Stewart, Betty Poon, Joo Y. Song, Irvin S. Y. Chen
Journal of Virology Apr 2000, 74 (7) 3105-3111; DOI: 10.1128/JVI.74.7.3105-3111.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation
Sheila A. Stewart, Betty Poon, Joo Y. Song, Irvin S. Y. Chen
Journal of Virology Apr 2000, 74 (7) 3105-3111; DOI: 10.1128/JVI.74.7.3105-3111.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

apoptosis
caspases
Gene Products, vpr
HIV-1

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514